China’s first mRNA Covid-19 vaccine approved for use in Indonesia

By Zhuang Pinghui

Indonesia has become the first country to approve a Chinese home-grown mRNA Covid-19 vaccine for emergency use.

The Indonesian Food and Drugs Agency on Thursday approved AWcorna for primary and booster use by people aged 18 years old and above, according to a report in China’s Communist Party mouthpiece People’s Daily.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
China , Vaccine , Indonesia

Next In Aseanplus News
Indonesia's tourist hotspot sets up flood alarms at six high-risk locations in Denpasar
Myanmar votes again in military's lopsided election; Junta-backed party on course to win with opposition absent
Ringgit gains against Singapore Dollar unlikely to hit trade
Korean peninsula arms race is heating up. How will China react in 2026?
Rising climate risks call for national disaster management council, says Lee Lam Thye
Uptrend seen for Bursa Malaysia this week; to stay in the 1,670-1,700 range
Balance of risks tilts modestly towards a firmer ringgit; to trade within 4.04-4.07 range against the US dollar from Monday (Jan 12)
Thailand imposes curfew in the southern province of Narathiwat after violent attacks
Govt prioritises cost of living, ease of doing business as key focus, says Fahmi
Aaron-Wooi Yik denied Malaysian Open title by world No. 1 Kim-Seo

Trending in AseanPlus

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.